|
Overalla |
By Region |
P-value for regional comparisonb
|
By Population |
P-value for population comparisonb
|
(n=870) |
South (n=260) |
Bekaa (n=279) |
GB/ML (n=331) |
Syrian(n=637) |
Lebanese (n=330) |
Point |
95% CI |
Point |
95% CI |
Point |
95% CI |
Point |
95% CI |
Point |
95% CI |
Point |
95% CI |
BMIc |
n=870 |
n=260 |
n=279 |
n=331 |
|
n=405 |
n=218 |
|
Total % patients with BMI measured |
7.7% |
(6.0-9.7%) |
4.2% |
(2.1-7.4%) |
0% |
(0.0-1.3%) |
16.9% |
(13.0-21.4%) |
< 0.001 |
10% |
(7.4-13.5%) |
11.9% |
(7.9-17.0%) |
0.488 |
|
n=67 |
n=11 |
n=0 |
n=56 |
|
n=41 |
n=26 |
|
Mean |
33.46 |
(31.85-35.08) |
31.71 |
(27.26-36.15) |
- |
- |
33.81 |
(32.04-35.58) |
0.339 |
33.12 |
(31.00-35.24) |
34.01 |
(31.36-36.65) |
0.598 |
BMI < 25 kg/m2 (normal) - “GOAL” |
7.5% |
(2.5-16.6%) |
9.1% |
(0.2-41.3%) |
- |
- |
7.1% |
(2.0-17.3%) |
0.875 |
7.3% |
(1.5-19.9%) |
7.7% |
(0.9-25.1%) |
0.885 |
BMI > 25kg/m2 (overweight) - “CAUTION”” |
22.4% |
(13.1-34.2%) |
27.3% |
(6.0-61.0%) |
- |
- |
21.4% |
(11.6-34.4%) |
24.4% |
(12.4-40.3%) |
19.2% |
(6.6-39.4%) |
BMI > 30kg/m2 (obese) - “HIGH RISK” |
70.1% |
(57.7-80.7%) |
63.6% |
(30.8-89.1%) |
- |
- |
71.4% |
(57.8-82.7%) |
68.3% |
(51.9-81.9%) |
73.1% |
(52.2-88.4%) |
|
Blood Lipid - Cholesterol (mg/dL) |
n=583 |
n=162 |
n=128 |
n=293 |
|
n=276 |
n=163 |
|
% total patients with blood lipid test |
30.2% |
(27.2-33.4%) |
29.2% |
(23.8-35.2%) |
12.2% |
(8.6-16.6%) |
46.2% |
(40.8-51.8%) |
< 0.001 |
29.4% |
(25.0-34.1%) |
44.5% |
(37.8-51.4%) |
0.003 |
|
n=263 |
n=76 |
n=34 |
n=153 |
|
n=119 |
n=97 |
|
Mean |
204 |
(198-210) |
218 |
(207-229) |
222 |
(201-243) |
194 |
(186-200) |
< 0.001 |
204 |
(196-212) |
195 |
(186-205) |
0.167 |
Cholesterol<200 mg/dL “GOAL” |
46.4% |
(40.2-52.6%) |
35.5% |
(24.9-47.3%) |
38.2% |
(22.2-56.4%) |
53.6% |
(45.4-61.7%) |
0.042 |
42.9% |
(33.8-52.3%) |
56.7% |
(46.3-66.7%) |
0.129 |
Cholesterol=200-239 mg/dL “CAUTION” |
33.1% |
(27.4-39.1%) |
35.5% |
(24.9-47.3%) |
35.3% |
(19.7-53.5%) |
31.4% |
(24.1-39.4%) |
37.0% |
(28.3-46.3%) |
27.8% |
(19.2-37.9%) |
Cholesterol>240 mg/dL “RISK” |
20.5% |
(15.8-25.9%) |
28.9% |
(19.1-40.5%) |
26.5% |
(12.9-44.4%) |
15.0% |
(9.8-21.7%) |
20.2% |
(13.4-28.5%) |
15.5% |
(8.9-24.2%) |
|
Hypertension |
n=755 |
n=206 |
n=238 |
n=311 |
|
n=353 |
n=185 |
|
Total % HT patients with BP measured |
49.1% |
(45.5-52.8%) |
35.9% |
(29.4-42.9%) |
22.3% |
(17.1-28.1%) |
78.5% |
(73.5-82.9%) |
< 0.001 |
60.1% |
(54.7-65.2%) |
62.7% |
(55.3-69.7%) |
0.550 |
|
n=371 |
n=74 |
n=53 |
n=244 |
|
n=212 |
n=116 |
|
Controlled: BP<140/90 mmHg |
64.2% |
(59.0-69.0%) |
47.3% |
(35.6-59.3%) |
39.6% |
(26.5-54.0%) |
74.6% |
(68.6-79.9%) |
< 0.001 |
59.9% |
(53.0-66.6%) |
74.1% |
(65.2-81.8%) |
0.028 |
Uncontrolled: Systolic BP > 140 mmHg (Diastolic BP < 90) |
21.8% |
(17.7-26.4%) |
32.4% |
(22.0-44.3%) |
22.6% |
(12.3-36.2%) |
18.4% |
(13.8-23.9%) |
24.5% |
(18.9-30.9%) |
17.2% |
(10.9-25.4%) |
Uncontrolled: Diastolic BP > 90 mmHg (Systolic BP<140) |
1.9% |
(0.8-3.8%) |
1.4% |
(0.0-7.3%) |
7.5% |
(2.1-18.2%) |
0.8% |
(0.1-2.9%) |
1.4% |
(0.3-4.1%) |
2.6% |
(0.5-7.4%) |
|
Uncontrolled: BP>140/90 mmHg |
12.1% |
(9.0-15.9%) |
18.9% |
(10.7-29.7%) |
30.2% |
(18.3-44.3%) |
6.1% |
(3.5-9.9%) |
14.2% |
(9.8-19.6%) |
6.0% |
(2.5-12.0%) |
|
Systolic blood pressure |
n=379 |
n=79 |
n=53 |
n=247 |
|
n=218 |
n=117 |
|
Mean (in mmHg) |
138 |
(136-140) |
148 |
(143-153) |
150 |
(144-156) |
132 |
(130-134) |
< 0.001 |
140 |
(137-143) |
133 |
(130-136) |
0.003 |
BP < 140 mmHg |
47.5% |
(42.4-52.7%) |
26.6% |
(17.3-37.7%) |
28.3% |
(16.8-42.3%) |
58.3% |
(51.9-64.5%) |
< 0.001 |
43.6% |
(36.9-50.4%) |
53.8% |
(44.4-63.1%) |
0.011 |
BP 140-149 mmHg |
20.3% |
(16.4-24.7%) |
19.0% |
(11.0-29.4%) |
24.5% |
(13.8-38.3%) |
19.8% |
(15.1-25.4%) |
19.3% |
(14.3-25.1%) |
24.8% |
(17.3-33.6%) |
BP 150-159 mmHg |
12.7% |
(9.5-16.4%) |
17.7% |
(10.0-27.9%) |
9.4% |
(3.1-20.7%) |
11.7% |
(8.0-16.4%) |
12.8% |
(8.7-18.0%) |
12.8% |
(7.4-20.3%) |
|
BP 160-169 mmHg |
10.0% |
(7.2-13.5%) |
13.9% |
(7.2-23.5%) |
13.2% |
(5.5-25.3%) |
8.1% |
(5.0-12.2%) |
11.9% |
(7.9-17.0%) |
5.1% |
(1.9-10.8%) |
|
BP>170 mmHg |
9.5% |
(6.7-12.9%) |
22.8% |
(14.1-33.6%) |
24.5% |
(13.8-38.3%) |
2.0% |
(0.7-4.7%) |
12.4% |
(8.3-17.5%) |
3.4% |
(0.9-8.5%) |
|
Diastolic Blood Pressure |
n=372 |
n=74 |
n=54 |
n=244 |
|
n=213 |
n=116 |
|
Mean (in mmHg) |
81 |
(79-82) |
85 |
(83-88) |
88 |
(84-93) |
78 |
(76-79) |
< 0.001 |
82 |
(80-83) |
78 |
(76-80) |
0.023 |
BP < 90 mmHg |
71.2% |
(66.3-75.8%) |
44.6% |
(33.0-56.6%) |
46.3% |
(32.6-60.4%) |
84.8% |
(79.7-89.1%) |
< 0.001 |
68.5% |
(61.8-74.7%) |
80.2% |
(71.7-87.0%) |
0.074 |
BP 90-99 mmHg |
17.7% |
(14.0-22.0%) |
36.5% |
(25.6-48.5%) |
29.6% |
(18.0-43.6%) |
9.4% |
(6.1-13.8%) |
18.8% |
(13.8-24.7%) |
12.9% |
(7.4-20.4%) |
BP 100-109 mmHg |
8.9% |
(6.2-12.2%) |
16.2% |
(8.7-26.6%) |
14.8% |
(6.6-27.1%) |
5.3% |
(2.9-8.9%) |
9.9% |
(6.2-14.7%) |
6.9% |
(3.0-13.1%) |
|
BP > 110 mmHg |
2.2% |
(0.9-4.2%) |
2.7% |
(0.3-9.4%) |
9.3% |
(3.1-20.3%) |
0.4% |
(0.0-2.3%) |
2.8% |
(1.0-6.0%) |
0.0% |
(0.0-3.1%) |
|
GB/ML = Greater Beirut/Mount Lebanon; 95% CI = 95% confidence interval; BMI = body mass index; HT = Hypertension; BP = blood pressure (in mmHg); a Includes Syrian refugee and Lebanese host community patients as well as enrolled patients with other nationalities; b Independent t-test for continuous variables, Chi-square test for categorical variables; c In kg/m2.